These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30917969)

  • 1. Low risk pragmatic trials do not always require participants' informed consent.
    Dal-Ré R; Avendaño-Solà C; Bloechl-Daum B; de Boer A; Eriksson S; Fuhr U; Holm S; James SK; Mentz RJ; Perucca E; Rosendaal FR; Treweek S
    BMJ; 2019 Mar; 364():l1092. PubMed ID: 30917969
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it time to discuss on low-intervention clinical trials without participants' informed consent?
    Dal-Ré R; Carné X
    Med Clin (Barc); 2018 May; 150(9):345-347. PubMed ID: 29196035
    [No Abstract]   [Full Text] [Related]  

  • 3. Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
    Taljaard M; Goldstein CE; Giraudeau B; Nicholls SG; Carroll K; Hey SP; Brehaut JC; Jairath V; London AJ; Eldridge SM; Grimshaw JM; Fergusson DA; Weijer C
    Clin Trials; 2020 Jun; 17(3):253-263. PubMed ID: 32367741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.
    Dal-Ré R; Avendaño-Solà C; de Boer A; James SK; Rosendaal FR; Stephens R; Ioannidis JPA
    J Clin Epidemiol; 2019 Oct; 114():60-71. PubMed ID: 31212001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics and regulatory complexities for pragmatic clinical trials.
    Sugarman J; Califf RM
    JAMA; 2014 Jun; 311(23):2381-2. PubMed ID: 24810723
    [No Abstract]   [Full Text] [Related]  

  • 6. Informed consent for comparative effectiveness trials.
    Schreiner MS
    N Engl J Med; 2014 May; 370(20):1958. PubMed ID: 24827053
    [No Abstract]   [Full Text] [Related]  

  • 7. Informed consent for comparative effectiveness trials.
    Anderson JR; Schonfeld TL
    N Engl J Med; 2014 May; 370(20):1958. PubMed ID: 24827052
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed consent for comparative effectiveness trials.
    Faden RR; Beauchamp TL; Kass NE
    N Engl J Med; 2014 May; 370(20):1959-60. PubMed ID: 24827051
    [No Abstract]   [Full Text] [Related]  

  • 9. Brief Report: Staged-informed Consent in the Cohort Multiple Randomized Controlled Trial Design.
    Young-Afat DA; Verkooijen HA; van Gils CH; van der Velden JM; Burbach JP; Elias SG; van Delden JJ; Relton C; van Vulpen M; van der Graaf R
    Epidemiology; 2016 May; 27(3):389-92. PubMed ID: 27035689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.
    Miller DG; Kim SYH; Li X; Dickert NW; Flory J; Runge CP; Relton C
    JAMA Netw Open; 2018 Dec; 1(8):e186149. PubMed ID: 30646316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trials--removing unnecessary obstacles.
    Reith C; Landray M; Devereaux PJ; Bosch J; Granger CB; Baigent C; Califf RM; Collins R; Yusuf S
    N Engl J Med; 2013 Sep; 369(11):1061-5. PubMed ID: 24024845
    [No Abstract]   [Full Text] [Related]  

  • 12. Participants' written informed consent in low-risk pragmatic clinical trials with medicines.
    Dal-Ré R
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):205-210. PubMed ID: 32073940
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical Considerations in Conducting Pragmatic Trials in Oncology.
    Hammer MJ
    Oncol Nurs Forum; 2017 Sep; 44(5):537-539. PubMed ID: 28820523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital ERs on the front line in informed-consent debate.
    Wolpe PR; Menz JF
    Forum Appl Res Public Policy; 1997; ():127-31. PubMed ID: 14628849
    [No Abstract]   [Full Text] [Related]  

  • 15. Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
    Kalkman S; van Thiel GJ; Grobbee DE; van Delden JJ
    Drug Discov Today; 2015 Jul; 20(7):856-62. PubMed ID: 25794600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waivers and Alterations to Consent in Pragmatic Clinical Trials: Respecting the Principle of Respect for Persons.
    Kim SY; Miller FG
    IRB; 2016; 38(1):1-5. PubMed ID: 26964403
    [No Abstract]   [Full Text] [Related]  

  • 17. [When the information provided to participants of a comparative effectiveness trial ends up in the court: The opening of Pandora's box?].
    Dal-Ré R; Omeñaca F; Gracia D
    Med Clin (Barc); 2016 Jul; 147(2):76-80. PubMed ID: 26961391
    [No Abstract]   [Full Text] [Related]  

  • 18. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial-blood study has critics seeing red.
    Guterman L
    Chron High Educ; 2006 Jun; 52(41):A17. PubMed ID: 16856302
    [No Abstract]   [Full Text] [Related]  

  • 20. Do doctors have a duty to take part in pragmatic randomised trials?
    Campbell MK; Weijer C; Goldstein CE; Edwards SJL
    BMJ; 2017 Jun; 357():j2817. PubMed ID: 28615179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.